Pharmacists in Gardnerville, Nevada


28 Pharmacists found in Gardnerville
female pharmacist

Marcy Rathjen Rouse


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1341 Us Highway 395 N, Gardnerville, NV 89410
775-782-0160    

male pharmacist

Dr. Matthew Patrick Stevens, PHARMD


Pharmacist
1363 Us Highway 395 N, Gardnerville, NV 89410
775-782-2226     775-782-1007

female pharmacist

Michaele Bacoch, R.PH


Pharmacist
1559 Watasheamu Rd, Gardnerville, NV 89460
775-265-4215    



female pharmacist

Dr. Nancy Therese Caddigan, PHARMD, RPH


Pharmacist
1559 Watasheamu Rd, Gardnerville, NV 89460
775-265-8622     775-265-3429

female pharmacist

Ms. Rebecca Finch, RPH


Pharmacist
1559 Watasheamu Rd, Gardnerville, NV 89460
775-265-4215     775-265-6071

male pharmacist

Mr. Robert Mai, R. PH.


Pharmacist
1559 Watasheamu Rd, Gardnerville, NV 89460
775-265-8622    

female pharmacist

Sanne Ly


Pharmacist
1342 Us Highway 395 N, Gardnerville, NV 89410
775-782-0537    

female pharmacist

Dr. Stacy Lynn Hardy, PHARMD


Pharmacist
1329 Us Highway 395 N Ste 1, Gardnerville, NV 89410
775-782-7042    

female pharmacist

Tamara Degiovanni, RPH


Pharmacist
1329 Us Highway 395 N, Gardnerville, NV 89410
775-782-5530    

female pharmacist

Dr. Tanya Marie Demichele, PHARMD


Pharmacist
1342 Us Highway 395 N, Gardnerville, NV 89410
775-782-0537     775-783-1973

female pharmacist

Violaine Marie Ahart


Pharmacist
1363 Us Highway 395 N, Gardnerville, NV 89410
775-782-2226     775-782-1007

male pharmacist

Wayne Veiock, PHARMD


Pharmacist
1329 Us Highway 395 N, #1, Gardnerville, NV 89410
775-782-7042    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.